Literature DB >> 22157361

Cocooning: a concept to protect young children from infectious diseases.

Alexandra P Grizas1, Deepa Camenga, Marietta Vázquez.   

Abstract

PURPOSE OF REVIEW: Despite focused efforts aimed at preventing infectious diseases among infants, recent years have seen a surge of infections among this population, particularly in pertussis, reminiscent of the 1940s prevaccine era. Given these trends, this review serves to discuss cocooning for infants against pertussis and its more recent application in influenza, and the barriers to and facilitators of this important strategy. RECENT
FINDINGS: Infection with pertussis and influenza remains a significant cause of hospitalization among infants aged less than 1 year. Simultaneously, uptake of both tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines is very low among adults reporting close contact with an infant. To date, widespread implementation of cocooning has been thwarted by both individual-level and system-level issues, although general acceptance of vaccination is high in settings in which cocooning is encouraged.
SUMMARY: Better characterization and improvement of the cocooning strategy are necessary. Additionally, longitudinal research evaluating the effectiveness of cocooning against pertussis and influenza is essential. Ultimately, the effectiveness of cocooning to produce sustained control of infections will be dependent on healthcare provider advocacy, patient education, implementation and enforcement of policies, and the development of cost-effective programs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22157361     DOI: 10.1097/MOP.0b013e32834e8fe9

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  10 in total

1.  The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.

Authors: 
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

2.  Lactoferrin acts as an adjuvant during influenza vaccination of neonatal mice.

Authors:  Michael P Sherman; Curtis J Pritzl; Chuan Xia; Mindy M Miller; Habib Zaghouani; Bumsuk Hahm
Journal:  Biochem Biophys Res Commun       Date:  2015-10-22       Impact factor: 3.575

3.  Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

Authors:  Roy E Strowd; Katrina Swett; Michele Harmon; Annette F Carter; Aurora Pop-Vicas; Michael Chan; Stephen B Tatter; Thomas Ellis; Maria Blevins; Kevin High; Glenn J Lesser
Journal:  Neuro Oncol       Date:  2014-04-08       Impact factor: 12.300

4.  COVID-19 Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Cost-Benefit Analysis.

Authors:  Mario Cesare Nurchis; Alberto Lontano; Domenico Pascucci; Martina Sapienza; Eleonora Marziali; Francesco Castrini; Rosaria Messina; Luca Regazzi; Francesco Andrea Causio; Andrea Di Pilla; Giuseppe Vetrugno; Gianfranco Damiani; Patrizia Laurenti
Journal:  Int J Environ Res Public Health       Date:  2022-06-26       Impact factor: 4.614

5.  Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated.

Authors:  J Collins; I Alona; R Tooher; H Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

6.  Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali.

Authors:  Andrea G Buchwald; Boubou Tamboura; Fadima C Haidara; Flanon Coulibaly; Moussa Doumbia; Fatoumata Diallo; Sarah Boudova; Adama M Keita; Samba O Sow; Karen Kotloff; Myron Levine; Milagritos D Tapia
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

7.  Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy.

Authors:  Roy E Strowd; Gregory Russell; Fang-Chi Hsu; Annette F Carter; Michael Chan; Stephen B Tatter; Adrian W Laxton; Martha A Alexander-Miller; Kevin High; Glenn J Lesser
Journal:  Neurooncol Pract       Date:  2018-01-06

8.  Influenza vaccination in pregnant women: a systematic review.

Authors:  Tais F Galvao; Marcus T Silva; Ivan R Zimmermann; Luiz Antonio B Lopes; Eneida F Bernardo; Mauricio G Pereira
Journal:  ISRN Prev Med       Date:  2013-11-07

9.  Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets.

Authors:  Amorsolo L Suguitan; James R Zengel; Scott Jacobson; Stephanie Gee; Janet Cetz; Paulyn Cha; Zhongying Chen; Rosemary Broome; Hong Jin
Journal:  Influenza Other Respir Viruses       Date:  2014-03       Impact factor: 4.380

10.  Different perspectives of immunizations during pregnancy

Authors:  Gökce Celep; Aysu Duyan Çamurdan; Fatma Nur Baran Aksakal; Osman Fadil Kara
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.